Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
___	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Increased	O
lower	O
extremity	O
edema	O
and	O
change	B-Delirium
in	B-Delirium
mental	B-Delirium
status	B-Delirium
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
This	O
is	O
an	O
___	O
yo	O
female	O
with	O
a	O
history	O
of	O
dementia,	B-Dementia
htn,	O
hypothyroidism,	O
TIA	O
(___)	O
who	O
is	O
being	O
transferred	O
to	O
the	O
CCU	O
for	O
hypotension,	O
hypoxia,	O
and	O
altered	B-Delirium
mental	B-Delirium
status.	B-Delirium
She	O
was	O
initially	O
admitted	O
overnight	O
on	O
___	O
to	O
the	O
general	O
medicine	O
service.	O
She	O
presented	O
from	O
a	O
long	B-Lives_in_carehome
term	B-Lives_in_carehome
care	B-Lives_in_carehome
facility	B-Lives_in_carehome
with	O
increased	O
confusion	O
and	O
new	O
lower	O
extremity	O
edema.	O
Her	O
daugheter	O
expressed	O
that	O
her	O
mother	O
had	O
decreased	O
appetite	O
and	O
confusion	B-Delirium
over	O
the	O
last	O
10	O
days.	O
Doctors	O
at	O
___	O
nursing	O
home	O
started	O
her	O
on	O
Remeron.	O
Per	O
her	O
nursing	O
facility	O
records	O
she	O
gained	O
10	O
lbs	O
in	O
2	O
days.	O
Presumably	O
for	O
this	O
reason	O
she	O
was	O
referred	O
for	O
a	O
cardiology	O
evaluation	O
(appt	O
scheduled	O
with	O
Dr.	O
___	O
___	O
However,	O
she	O
became	O
increasingly	O
confused	B-Delirium
and	O
unable	O
to	O
take	O
PO,	O
so	O
she	O
was	O
referred	O
to	O
___	O
ED.	O
.	O
In	O
the	O
ED,	O
VS:	O
96.4	O
73	O
123/91	O
18	O
97%	O
on	O
4L.	O
Patient	O
agitated	B-Delirium
and	O
given	O
haldol	O
5mg	O
IV	O
x	O
1.	O
She	O
also	O
received	O
1mg	O
IV	O
ativan	O
prior	O
to	O
CT	O
head	O
which	O
was	O
negative.	O
A	O
CXR	O
showed	O
bilateral	O
pleural	O
effusions	O
L>R	O
and	O
moderate	O
pulmonary	O
edema.	O
ECG	O
was	O
read	O
as	O
unchanged	O
from	O
prior	O
tracing	O
___.	O
Troponin	O
was	O
.29,	O
rising	O
to	O
0.36.	O
BNP	O
was	O
>8000.	O
Cardiology	O
was	O
consulted	O
and	O
felt	O
this	O
troponin	O
bump	O
most	O
likely	O
attributed	O
to	O
heart	O
failure	O
rather	O
than	O
ACS.	O
Patient	O
admitted	O
to	O
medicine	O
for	O
further	O
work-up	O
of	O
CHF.	O
.	O
Upon	O
arrival	O
to	O
the	O
floor,	O
patient	O
had	O
a	O
4	O
L	O
O2	O
requirement	O
and	O
appeared	O
volume	O
overloaded.	O
ABG	O
___	O
on	O
4L.	O
She	O
was	O
given	O
80	O
mg	O
IV	O
lasix,	O
after	O
which	O
she	O
made	O
700	O
cc	O
urine	O
within	O
1	O
hour.	O
SBP	O
fell	O
from	O
baseline	O
140s	O
to	O
a	O
low	O
of	O
67.	O
Her	O
mental	O
status	O
continued	O
to	O
be	O
arousable	O
but	O
drowsy.	O
She	O
was	O
given	O
~100	O
cc	O
NS	O
and	O
SBP	O
rose	O
into	O
the	O
___.	O
Notably,	O
her	O
respiratory	O
status	O
apparently	O
improved	O
and	O
O2	O
Sats	O
rose	O
to	O
upper	O
___	O
on	O
4L.	O
.	O
There	O
was	O
suspicion	O
for	O
pulmonary	O
embolism	O
as	O
a	O
cause	O
of	O
her	O
hypoxia.	O
CT	O
for	O
PE	O
could	O
not	O
be	O
done	O
secondary	O
to	O
poor	O
renal	O
function.	O
Echocardiocardiogram	O
was	O
done	O
to	O
evaluate	O
for	O
signs	O
of	O
R	O
heart	O
strain,	O
and	O
indeed	O
demonstrated	O
severe	O
RV	O
dilatation	O
and	O
abnormal	O
septal	O
motion	O
consistent	O
with	O
RV	O
pressure/volume	O
overload	O
new	O
compared	O
to	O
prior	O
echo	O
___.	O
PA	O
pressures	O
could	O
not	O
be	O
estimated.	O
Small	O
pericardial	O
effusion	O
was	O
also	O
noted.	O
Heparin	O
gtt	O
without	O
initial	O
bolus	O
was	O
started	O
for	O
empiric	O
treatment	O
of	O
PE.	O
.	O
The	O
patient's	O
urine	O
output	O
trailed	O
off	O
to	O
~15cc/h,	O
her	O
SBP	O
remained	O
in	O
the	O
___,	O
and	O
her	O
mental	O
status	O
continued	O
to	O
be	O
suboptimal.	O
Thus,	O
transfer	O
to	O
the	O
CCU	O
was	O
initiated	O
for	O
workup	O
of	O
new	O
RV	O
dilatation,	O
apparent	O
R	O
sided	O
heart	O
failure,	O
further	O
diuresis	O
in	O
the	O
setting	O
of	O
borderline	O
hypotension	O
and	O
preload	O
dependence,	O
and	O
altered	B-Delirium
mental	B-Delirium
status.	B-Delirium
.	O
On	O
arrival	O
to	O
the	O
CCU,	O
patient	O
was	O
initially	O
lethargic	O
and	O
could	O
provide	O
only	O
limited	O
information.	O
She	O
denied	O
any	O
difficulty	O
breathing	O
or	O
chest	O
pain.	O
She	O
further	O
denied	O
nausea	O
or	O
abdominal	O
pain.	O
Her	O
only	O
complaint	O
is	O
feeling	O
extremely	O
cold.	O
Past	O
Medical	O
History:	O
(per	O
nursing	O
facility	O
records	O
and	O
OMR):	O
HTN	O
TIA	O
Dementia	B-Dementia
Hypothyroidism,	O
hx	O
Graves	O
disease,	O
s/p	O
RAI	O
Rx	O
1940s	O
Anemia	O
Urge	B-Urinary_incontinence
Incontinence	B-Urinary_incontinence
Osteopenia	O
Vitamin	O
B12	O
deficiency	O
Social	O
History:	O
___	O
Family	O
History:	O
Per	O
daughter:	O
Brother	O
with	O
colon	O
cancer	O
in	O
his	O
___	O
or	O
___.	O
Sister	O
with	O
breast	O
cancer	O
in	O
her	O
___.	O
Another	O
sister	O
with	O
thyroid	O
cancer,	O
?kidney/pancreas	O
mass.	O
Per	O
OMR:	O
Her	O
mother	O
"dropped	O
dead"	O
in	O
her	O
___	O
in	O
front	O
of	O
her	O
(sudden	O
death).	O
Her	O
sister	O
"dropped	O
dead"	O
at	O
age	O
___	O
in	O
front	O
of	O
her	O
(sudden	O
death).	O
Her	O
father	O
died	O
in	O
his	O
___	O
of	O
unknown	O
cause,	O
and	O
had	O
a	O
history	O
of	O
arthritis.	O
She	O
has	O
11	O
siblings	O
who	O
have	O
died,	O
none	O
suddenly	O
or	O
from	O
known	O
cardiac	O
causes.	O
Physical	O
Exam:	O
Vitals	O
-	O
Temp	O
99.6	O
Rectally	O
BP	O
146/53	O
HR	O
71	O
RR	O
23	O
Sat	O
99%	O
3L	O
NC	O
GENERAL:	O
lethargic	O
appearing	O
___	O
female,	O
arousable	O
to	O
sternal	O
rub	O
and	O
drowsy	O
during	O
examination	O
HEENT:	O
Normocephalic,	O
atraumatic.	O
No	O
scleral	O
icterus.	O
pupils	O
constricted	O
bilaterally.	O
MMM.	O
OP	O
clear.	O
Neck	O
Supple,	O
No	O
LAD	O
CARDIAC:	O
Regular	O
rhythm,	O
normal	O
rate.	O
Normal	O
S1,	O
Split	O
S2.	O
No	O
murmurs,	O
rubs	O
or	O
gallops.	O
No	O
pericardial	O
knock.	O
Appropriate	O
decrease	O
in	O
JVP	O
with	O
respirations.	O
No	O
pulsus	O
parodoxus.	O
No	O
hepatojugular	O
reflex	O
appreciated.	O
LUNGS:	O
Dependent	O
crackles	O
currently	O
laying	O
on	O
the	O
left	O
side.	O
Decreased	O
breath	O
sounds	O
at	O
the	O
bases.	O
ABDOMEN:	O
Normal	O
active	O
BS.	O
Soft,	O
NT,	O
ND.	O
No	O
HSM	O
EXTREMITIES:	O
2+	O
___	O
edema	O
R>L	O
Dopplerable	O
___	O
bilaterally.	O
SKIN:	O
No	O
rashes/lesions,	O
ecchymoses.	O
Scar	O
on	O
right	O
shin	O
well	O
healed.	O
NEURO:	O
AOx	B-Delirium
1	B-Delirium
(person)	O
she	O
is	O
under	O
the	O
impression	O
that	O
she's	O
currently	O
at	O
___	O
Moving	O
all	O
4	O
extremities.	O
Unable	O
to	O
perform	O
rest	O
of	O
neurologic	O
evaluation	O
given	O
pt	O
would	O
not	O
comply.	O
Grossly	O
face	O
is	O
symmetric.	O
Pertinent	O
Results:	O
LABS	O
ON	O
ADMISSION:	O
___	O
07:45PM	O
BLOOD	O
WBC-4.7	O
RBC-5.97*#	O
Hgb-14.8	O
Hct-44.3#	O
MCV-74*	O
MCH-24.7*#	O
MCHC-33.4	O
RDW-17.7*	O
Plt	O
___	O
___	O
07:45PM	O
BLOOD	O
Neuts-71.8*	O
___	O
Monos-6.8	O
Eos-0.4	O
Baso-0.2	O
___	O
11:30AM	O
BLOOD	O
___	O
PTT-40.1*	O
___	O
___	O
07:45PM	O
BLOOD	O
Glucose-131*	O
UreaN-21*	O
Creat-1.3*	O
Na-134	O
K-4.6	O
Cl-104	O
HCO3-22	O
AnGap-13	O
___	O
07:45PM	O
BLOOD	O
Free	O
T4-1.3	O
___	O
07:45PM	O
BLOOD	O
TSH-3.7	O
___	O
07:45PM	O
BLOOD	O
Calcium-8.8	O
Phos-3.7	O
Mg-2.1	O
CARDIAC	O
ENZYMES:	O
___	O
07:45PM	O
BLOOD	O
CK(CPK)-55;	O
CK-MB-5	O
proBNP-8096*;	O
cTropnT-0.29*	O
___	O
01:08AM	O
BLOOD	O
CK-MB-5;	O
cTropnT-0.36*	O
___	O
11:30AM	O
BLOOD	O
CK(CPK)-135;	O
CK-MB-5	O
cTropnT-0.43*	O
___	O
07:00PM	O
BLOOD	O
CK(CPK)-114;	O
CK-MB-5	O
cTropnT-0.44*	O
___	O
01:25AM	O
BLOOD	O
CK(CPK)-97;	O
CK-MB-NotDone	O
cTropnT-0.46*	O
___	O
04:45AM	O
BLOOD	O
cTropnT-0.36*	O
RELEVANT	O
INTERVAL	O
LABS	O
___	O
11:40PM	O
BLOOD	O
LMWH-0.4	O
___	O
11:30AM	O
BLOOD	O
Albumin-3.1*	O
Calcium-8.3*	O
Phos-3.5	O
Mg-2.0	O
___	O
11:30AM	O
BLOOD	O
D-Dimer-5451*	O
LABS	O
AT	O
DISCHARGE:	O
___	O
07:30AM	O
BLOOD	O
WBC-4.4	O
RBC-5.37	O
Hgb-13.1	O
Hct-40.1	O
MCV-75*	O
MCH-24.4*	O
MCHC-32.7	O
RDW-18.7*	O
Plt	O
___	O
___	O
07:30AM	O
BLOOD	O
___	O
PTT-68.9*	O
___	O
___	O
07:30AM	O
BLOOD	O
Glucose-101	O
UreaN-20	O
Creat-1.1	O
Na-145	O
K-4.0	O
Cl-110*	O
HCO3-26	O
AnGap-13	O
MICROBIOLOGY	O
___	O
Urine	O
Cx:	O
No	O
growth.	O
___	O
Blood	O
Cx:	O
No	O
growth.	O
___	O
Blood	O
Cx:	O
No	O
growth.	O
STUDIES:	O
ECG	O
___:	O
Sinus	O
rhythm.	O
Consider	O
left	O
atrial	O
abnormality.	O
Indeterminate	O
axis.	O
There	O
is	O
an	O
SI-Q3-T3	O
pattern.	O
Modest	O
right	O
ventricular	O
conduction	O
delay	O
pattern.	O
Delayed	O
R	O
wave	O
progression	O
with	O
late	O
precordial	O
QRS	O
transition.	O
Diffuse	O
T	O
wave	O
abnormalities.	O
Findings	O
are	O
non-specific	O
but	O
clinical	O
correlation	O
is	O
suggested	O
for	O
possible	O
right	O
ventricular	O
overload.	O
Compared	O
to	O
the	O
previous	O
tracing	O
of	O
___	O
findings	O
as	O
outlined	O
are	O
now	O
present.	O
ECHO	O
___:	O
The	O
left	O
atrium	O
is	O
normal	O
in	O
size.	O
Left	O
ventricular	O
wall	O
thickness,	O
cavity	O
size,	O
and	O
global	O
systolic	O
function	O
are	O
normal	O
(LVEF>55%).	O
Due	O
to	O
suboptimal	O
technical	O
quality,	O
a	O
focal	O
wall	O
motion	O
abnormality	O
cannot	O
be	O
fully	O
excluded.	O
The	O
right	O
ventricular	O
cavity	O
is	O
markedly	O
dilated.	O
Right	O
ventricular	O
regional	O
function	O
cannot	O
be	O
assessed.	O
There	O
is	O
abnormal	O
systolic	O
septal	O
motion/position	O
consistent	O
with	O
right	O
ventricular	O
pressure	O
overload.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened	O
but	O
aortic	O
stenosis	O
is	O
not	O
present.	O
Trace	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
mild	O
mitral	O
valve	O
prolapse.	O
Trivial	O
mitral	O
regurgitation	O
is	O
seen.	O
The	O
supporting	O
structures	O
of	O
the	O
tricuspid	O
valve	O
are	O
thickened/fibrotic.	O
There	O
is	O
at	O
least	O
borderline	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
a	O
small	O
pericardial	O
effusion.	O
The	O
effusion	O
appears	O
circumferential.	O
IMPRESSION:	O
Suboptimal	O
image	O
quality.	O
Severe	O
right	O
ventricular	O
dilation.	O
Abnormal	O
septal	O
motion	O
consistent	O
with	O
right	O
ventricular	O
pressure/volume	O
overload.	O
Pulmonary	O
pressures	O
cannot	O
be	O
adequately	O
assessed.	O
Preserved	O
global	O
systolic	O
function.	O
Small	O
circumferential	O
pericardial	O
effusion.	O
Compared	O
with	O
the	O
prior	O
study	O
(images	O
reviewed)	O
of	O
___,	O
severe	O
right	O
ventircular	O
dilation	O
is	O
now	O
present.	O
The	O
right	O
ventricle	O
appears	O
to	O
have	O
been	O
mild	O
to	O
moderately	O
dilated	O
on	O
prior	O
study,	O
but	O
views	O
were	O
limited.	O
CXR	O
___:	O
AP	O
chest	O
compared	O
to	O
___,	O
3:46	O
a.m.,	O
heterogeneous	O
bibasilar	O
opacification	O
has	O
worsened.	O
In	O
the	O
setting	O
of	O
progressive	O
moderate-to-severe	O
cardiomegaly	O
and	O
upper	O
lobe	O
vascular	O
engorgement,	O
this	O
is	O
most	O
readily	O
explained	O
by	O
dependent	O
pulmonary	O
edema,	O
but	O
pneumonia	B-Lower_respiratory_tract_infection
particularly	O
aspiration	O
could	O
be	O
contributing.	O
Bilateral	O
pleural	O
effusion	O
is	O
at	O
least	O
small.	O
Leftward	O
deviation	O
of	O
the	O
trachea	O
at	O
the	O
thoracic	O
inlet	O
developed	O
since	O
___	O
could	O
be	O
due	O
to	O
progressive	O
tortuosity	O
of	O
the	O
innominate	O
artery	O
or	O
interval	O
development	O
of	O
a	O
space-occupying	O
lesion,	O
most	O
commonly	O
a	O
goiter	O
but	O
not	O
necessarily	O
benign.	O
When	O
feasible,	O
clinical	O
evaluation	O
is	O
recommended.	O
CXR	O
___:	O
Opacification	O
at	O
the	O
lung	O
bases	O
is	O
improving	O
and	O
moderate	O
cardiomegaly	O
may	O
have	O
improved	O
as	O
well	O
all	O
pointing	O
toward	O
decreasing	O
cardiac	O
decompensation	O
and	O
improving	O
pulmonary	O
edema.	O
Small	O
bilateral	O
pleural	O
effusions	O
persist	O
left	O
greater	O
than	O
right.	O
The	O
greater	O
extent	O
of	O
opacification	O
at	O
the	O
left	O
lung	O
base	O
makes	O
pneumonia	O
a	O
possibility.	O
Leftward	O
displacement	O
of	O
the	O
trachea	O
at	O
the	O
thoracic	O
inlet	O
points	O
to	O
a	O
space	O
occupying	O
lesion	O
such	O
as	O
a	O
goiter,	O
but	O
requires	O
evaluation	O
since	O
this	O
is	O
a	O
new	O
finding	O
since	O
___.	O
Dr.	O
___	O
was	O
paged.	O
EKG	O
___:	O
Sinus	O
rhythm.	O
Non-specific	O
ST-T	O
wave	O
changes.	O
Compared	O
to	O
the	O
previous	O
tracing	O
of	O
___	O
ventricular	O
ectopy	O
is	O
resolved.	O
CTA	O
Chest	O
___:	O
Dilatation	O
of	O
the	O
right	O
atrium,	O
ventricle,	O
and	O
pulmonary	O
artery	O
with	O
filling	O
defect	O
in	O
the	O
main	O
pulmonary	O
artery	O
which	O
extends	O
into	O
the	O
left	O
pulmonary	O
arteries.	O
There	O
is	O
also	O
bowing	O
of	O
the	O
interventricular	O
septum	O
suggesting	O
right	O
heart	O
strain.	O
This	O
filling	O
defect	O
in	O
the	O
pulmonary	O
artery	O
could	O
represent	O
a	O
saddle	O
embolism,	O
however,	O
due	O
to	O
the	O
increased	O
density	O
of	O
contrast	O
and	O
early	O
bolus	O
timing,	O
mixing	O
artifact	O
in	O
the	O
pulmonary	O
artery	O
should	O
also	O
be	O
considered.	O
The	O
case	O
was	O
discussed	O
with	O
Dr.	O
___	O
a	O
decision	O
to	O
anticoagulate	O
and	O
repeat	O
the	O
study	O
at	O
a	O
later	O
date	O
was	O
planned	O
due	O
to	O
elevated	O
creatinine.	O
Moderate-to-large	O
bilateral	O
pleural	O
effusions.	O
Brief	O
Hospital	O
Course:	O
___	O
yo	O
female	O
with	O
dementia	B-Dementia
(AAO	O
x	O
___,	O
CAD	O
s/p	O
NSTEMI	O
in	O
___,	O
TIA	O
in	O
___,	O
hypothyroidism,	O
stable	O
meningioma	O
p/w	O
increased	O
lethargy,	O
weight	O
gain,	O
and	O
___	O
edema,	O
hypoxic	O
to	O
94%	O
4L	O
on	O
presentation	O
found	O
to	O
be	O
in	O
acute	O
right	O
sided	O
diastolic	O
failure	O
secondary	O
to	O
pulmonary	O
embolism.	O
1.	O
Acute	O
diastolic	O
right	O
heart	O
failure:	O
On	O
TTE,	O
pt	O
with	O
severe	O
RV	O
dilatation	O
new	O
since	O
___,	O
at	O
least	O
borderline	O
PA	O
systolic	O
HTN,	O
and	O
nl	O
LVEF.	O
LENIs	O
negative	O
and	O
subsequent	O
CTA	O
equivocal	O
(saddle-embolic	O
v.	O
mixing	O
artifact	O
w/	O
suboptimal	O
study)	O
but	O
submassive-massive	O
subacute	O
PE	O
most	O
likely	O
etiology	O
of	O
RV	O
failure;	O
LV	O
failure	O
may	O
have	O
been	O
due	O
to	O
RV	O
impingement	O
of	O
LV	O
filling.	O
Pt	O
was	O
started	O
on	O
heparin	O
for	O
treatment	O
of	O
PE,	O
and	O
later	O
transitioned	O
to	O
warfarin	O
5mg	O
with	O
lovenox	O
bridging.	O
Lovenox	O
was	O
discontinued	O
on	O
___	O
given	O
supratherapeutic	O
INR	O
of	O
3.2,	O
and	O
warfarin	O
held	O
___	O
and	O
restarted	O
at	O
2.5mg	O
on	O
___.	O
Pt's	O
INR	O
to	O
be	O
monitored	O
at	O
___	O
with	O
goal	O
INR	O
___.	O
She	O
will	O
likely	O
require	O
at	O
least	O
a	O
one-year	O
course	O
of	O
anticoagulation	O
given	O
her	O
degree	O
of	O
cardiac	O
impairment,	O
with	O
the	O
duration	O
to	O
be	O
weighed	O
against	O
the	O
risk	O
of	O
bleed.	O
Her	O
ASA	O
was	O
decreased	O
to	O
81mg	O
daily	O
given	O
starting	O
of	O
warfarin.	O
2.	O
Left	O
heart	O
failure:	O
Pt	O
fluid	O
overloaded	O
on	O
presentation.	O
TTE	O
showed	O
nl	O
EF	O
although	O
some	O
degree	O
of	O
diastolic	O
dysfunction	O
was	O
suspected.	O
It	O
was	O
postulated	O
that	O
RV	O
dilatation	O
have	O
been	O
impinging	O
on	O
LV	O
filling	O
and	O
forward	O
flow	O
due	O
to	O
the	O
septal	O
wall	O
motion	O
abnormality	O
observed.	O
Pt	O
was	O
transferred	O
to	O
CCU	O
initially	O
as	O
she	O
became	O
hemodynamically	O
unstable	O
in	O
the	O
setting	O
of	O
diuresis,	O
likely	O
due	O
to	O
her	O
preload	O
dependence.	O
In	O
the	O
CCU,	O
she	O
was	O
first	O
diuresed	O
with	O
a	O
furosemide	O
drip,	O
then	O
transitioned	O
to	O
IV	O
boluses	O
and	O
with	O
good	O
effect.	O
She	O
was	O
transferred	O
back	O
to	O
the	O
floor	O
after	O
~2.5L	O
diuresis	O
with	O
stable	O
BP	O
and	O
O2	O
sats	O
90-94%	O
RA.	O
She	O
appeared	O
to	O
have	O
improving	O
forward	O
flow	O
and	O
on	O
discharge,	O
O2sat	O
93%	O
on	O
RA	O
and	O
furosemide	O
requirement	O
20	O
mg	O
PO	O
daily,	O
with	O
possibility	O
of	O
weaning	O
patient	O
off	O
furosemide	O
in	O
outpatient	O
setting.	O
Patient	O
did	O
have	O
some	O
desaturation	O
to	O
___	O
during	O
night,	O
possibly	O
OSA,	O
but	O
CPAP	O
would	O
not	O
be	O
tolerated	O
due	O
to	O
her	O
dementia.	O
.	O
3.	O
Acute	O
renal	O
failure:	O
Baseline	O
creatinine	O
0.9.	O
On	O
admission,	O
it	O
was	O
1.3,	O
reaching	O
a	O
peak	O
of	O
1.4	O
in	O
the	O
CCU.	O
This	O
was	O
thought	O
secondary	O
to	O
poor	O
forward	O
flow	O
in	O
the	O
setting	O
of	O
CHF.	O
This	O
improved	O
back	O
to	O
baseline	O
with	O
diuresis.	O
She	O
did	O
receive	O
Mucomyst	O
for	O
her	O
CTA	O
chest,	O
and	O
all	O
of	O
her	O
medications	O
were	O
renally	O
dosed.	O
.	O
4.	O
Confusion/Lethargy:	O
Patient	O
with	O
waxing	O
and	O
waning	O
level	O
of	O
consciousness	O
on	O
admission	O
as	O
well	O
as	O
intermittent	O
disorientation.	O
This	O
was	O
likely	O
secondary	O
to	O
medication	O
effect	O
from	O
ativan	O
and	O
haldol	O
received	O
in	O
the	O
ED	O
as	O
well	O
as	O
due	O
to	O
acute	O
illness	O
including	O
hypoxia	O
and	O
hypotension.	O
CT	O
head	O
negative;	O
urine	O
culture	O
negative,	O
and	O
blood	O
cultures	O
with	O
no	O
growth;	O
TFTs	O
nl;	O
electrolytes	O
nl;	O
BUN	O
elevated	O
but	O
not	O
frankly	O
uremic	O
level.	O
Her	O
Remeron	O
(started	O
recently	O
for	O
anorexia)	O
was	O
held.	O
Her	O
mental	O
status	O
significantly	O
improved	O
within	O
___ecoming	O
more	O
animated	O
and	O
interactive	O
although	O
she	O
was	O
unable	O
to	O
state	O
the	O
season,	O
DOB,	O
and	O
where	O
she	O
currently	O
resides.	O
She	O
did	O
have	O
several	O
nights	O
of	O
agitation	O
requiring	O
soft	O
restraints	O
and	O
IV	O
Haldol,	O
but	O
2	O
nights	O
before	O
discharge,	O
patient	O
slept	O
through	O
the	O
night	O
and	O
did	O
not	O
require	O
chemical	O
or	O
mechanical	O
restraints.	O
Patient	O
was	O
oriented	O
x1	O
by	O
discharge,	O
which	O
appears	O
to	O
be	O
similar	O
to	O
baseline	O
dementia.	O
.	O
5.	O
Anorexia:	O
Daughter	O
and	O
HCP	O
reported	O
declining	O
ability	O
to	O
take	O
PO.	O
Possibly	O
secondary	O
to	O
worsening	O
dementia	O
vs.	O
___	O
medical	O
illness.	O
Remeron	O
was	O
recently	O
started	O
for	O
this,	O
unclear	O
if	O
this	O
had	O
been	O
helpful.	O
As	O
mentioned	O
above	O
her	O
Remeron	O
was	O
held	O
since	O
it	O
was	O
thought	O
to	O
possibly	O
be	O
contributing	O
to	O
her	O
change	O
in	O
mental	O
status.	O
A	O
nutrition	O
consult	O
was	O
requested,	O
and	O
they	O
recommended	O
low	O
sodium	O
diet	O
of	O
pureed	O
solids,	O
thin	O
liquids,	O
and	O
Ensure	O
supplements.	O
Because	O
the	O
patient	O
did	O
not	O
consistently	O
finish	O
PO	O
meals,	O
nutrition	O
recommended	O
1584	O
Kcal/70g	O
protein	O
tube	O
feeds	O
at	O
55	O
ml/hr	O
if	O
it	O
was	O
consistent	O
with	O
the	O
patient's	O
goals	O
of	O
care.	O
The	O
patient's	O
guardian	O
___	O
stated	O
that	O
tube	O
feeds	O
were	O
not	O
desired	O
at	O
this	O
time.	O
A	O
speech	O
and	O
swallow	O
consult	O
was	O
sought	O
since	O
patient	O
has	O
dementia	O
and	O
is	O
at	O
risk	O
for	O
aspiration.	O
We	O
encourage	O
supervised	O
feedings	O
once	O
the	O
patient	O
returns	O
to	O
her	O
nursing	O
home.	O
.	O
6.	O
Bradycardia:	O
Pt	O
had	O
been	O
on	O
metoprolol	O
per	O
___	O
records	O
although	O
this	O
had	O
been	O
discontinued	O
per	O
her	O
most	O
recent	O
PCP	O
note	O
in	O
___	O
due	O
to	O
possible	O
role	O
in	O
TIA.	O
She	O
also	O
had	O
been	O
noted	O
to	O
have	O
asymptomatic	O
episodes	O
of	O
bradycardia	O
to	O
___	O
in	O
the	O
past	O
which	O
were	O
also	O
observed	O
on	O
this	O
admission.	O
For	O
these	O
reasons,	O
her	O
metoprolol	O
was	O
once	O
again	O
discontinued	O
on	O
this	O
admission.	O
Medications	O
on	O
Admission:	O
Senna	O
2	O
tabs	O
qhs	O
ASA	O
325	O
mg	O
daily	O
Vitamin	O
B12	O
1000mcg	O
daily	O
Synthroid	O
___	O
mcg	O
daily	O
Simvastatin	O
40mg	O
daily	O
Colace	O
1	O
cap	O
BID	O
Mylanta	O
30ml	O
BID	O
Robitussin	O
10mg	O
Q4:	O
PRN	O
cough	O
Tylenol	O
___	O
Q6hrs:PRN	O
Milk	O
of	O
Mag	O
PRN	O
Fleet	O
Enema	O
PRN	O
Remeron	O
Discharge	O
Medications:	O
1.	O
Simvastatin	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
2.	O
Levothyroxine	O
125	O
mcg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
3.	O
Aspirin	O
81	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
DAILY	O
(Daily).	O
4.	O
Senna	O
8.6	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
HS	O
(at	O
bedtime)	O
as	O
needed	O
for	O
constipation.	O
5.	O
Cyanocobalamin	O
100	O
mcg	O
Tablet	O
Sig:	O
Ten	O
(10)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
6.	O
Docusate	O
Sodium	O
50	O
mg/5	O
mL	O
Liquid	O
Sig:	O
One	O
Hundred	O
(100)	O
mg	O
PO	O
BID	O
(2	O
times	O
a	O
day)	O
as	O
needed	O
for	O
constipation.	O
7.	O
Acetaminophen	O
325	O
mg	O
Tablet	O
Sig:	O
___	O
Tablets	O
PO	O
Q6H	O
(every	O
6	O
hours)	O
as	O
needed	O
for	O
pain.	O
8.	O
Furosemide	O
20	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
9.	O
Warfarin	O
2.5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
Once	O
Daily	O
at	O
4	O
___.	O
10.	O
Milk	O
of	O
Magnesia	O
400	O
mg/5	O
mL	O
Suspension	O
Sig:	O
___	O
ml	O
PO	O
twice	O
a	O
day	O
as	O
needed	O
for	O
constipation.	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary:	O
-	O
Massive	O
pulmonary	O
embolism	O
-	O
Acute	O
diastolic	O
heart	O
failure	O
-	O
Non-thrombotic	O
troponin	O
elevation	O
-	O
Acute	O
renal	O
failure	O
-	O
Delirium	O
Secondary	O
diagnosis:	O
-	O
Hypothyroidism	O
-	O
Hypertension	O
-	O
Dementia	O
Discharge	O
Condition:	O
Stable	O
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
with	O
increased	O
lower	O
extremity	O
swelling,	O
increased	O
weakness,	O
weight	O
gain,	O
and	O
decreased	O
oxygenation.	O
You	O
were	O
found	O
to	O
have	O
a	O
clot	O
in	O
your	O
lung	O
that	O
was	O
responsible	O
for	O
fluid	O
overload.	O
You	O
were	O
initially	O
admitted	O
to	O
the	O
cardiac	O
intensive	O
care	O
unit	O
and	O
was	O
treated	O
with	O
medications	O
to	O
decrease	O
fluid	O
overload.	O
You	O
were	O
also	O
started	O
on	O
blood	O
thinning	O
medications.	O
Please	O
continue	O
your	O
home	O
medications	O
with	O
the	O
following	O
additions	O
and	O
changes:	O
-	O
You	O
need	O
to	O
take	O
warfarin	O
(Coumadin)	O
blood	O
thinning	O
pills.	O
-	O
You	O
need	O
to	O
take	O
furosemide	O
(Lasix)	O
to	O
prevent	O
fluid	O
buildup.	O
-	O
Please	O
stop	O
taking	O
your	O
metoprolol	O
due	O
to	O
slow	O
heart	O
rate.	O
-	O
Please	O
stop	O
taking	O
your	O
Remeron	O
due	O
to	O
leading	O
to	O
increased	O
sleepiness.	O
Please	O
weigh	O
yourself	O
daily.	O
Please	O
call	O
your	O
primary	O
care	O
physician	O
or	O
return	O
to	O
the	O
hospital	O
if	O
you	O
experience	O
any	O
increased	O
shortness	O
of	O
breath,	O
palpitations,	O
chest	O
pain,	O
lower	O
extremity	O
swelling,	O
if	O
you	O
gain	O
more	O
than	O
3	O
lbs,	O
or	O
for	O
any	O
other	O
concerning	O
symptoms.	O
Followup	O
Instructions:	O
___	O

